International

EU to negotiate major vaccine contract extension with Pfizer

A healthcare worker administers a dose of the "Comirnaty" Pfizer BioNTech COVID-19 vaccine at the Parc des Expositions in Angers as part of the coronavirus disease (COVID-19) vaccination campaign in France, April 13, 2021.   | Photo Credit: REUTERS

EU Commission chief Ursula von der Leyen announced plans Wednesday for a major contract extension for COVID-19 vaccines with Pfizer stretching to 2023.

In a sign of confidence in a company that has been a mainstay of Europe's vaccination drive so far, Ms. von der Leyen said the EU will start negotiating to buy 1.8 billion doses of the Pfizer-BioNTech vaccine through 2023.

Ms. von der Leyen expressed full confidence in the technology used for the Pfizer-BioNTech vaccine, which is different from the one used for the Oxford-AstraZeneca vaccine.

“We need to focus on the technologies that have proven their worth,” Ms. von der Leyen said.

The European Commission currently has a portfolio of 2.3 billion doses from a half dozen companies and is negotiating more contracts.

This article is closed for comments.
Please Email the Editor

Printable version | May 11, 2021 8:13:05 PM | https://www.thehindu.com/news/international/eu-to-negotiate-major-vaccine-contract-extension-with-pfizer/article34318886.ece

Next Story